Front Cell Infect Microbiol
February 2023
Background: The increasing prevalence of invasive fungal infections in immuno-compromised patients is a considerable cause of morbidity and mortality. With the rapid emergence of antifungal resistance and an inadequate pipeline of new therapies, novel treatment strategies are now urgently required.
Methods: The antifungal activity of the alginate oligosaccharide OligoG in conjunction with nystatin was tested against a range of spp.